Article Information
vol. 3 no. 19
- Received May 30, 2017
- Revision received September 27, 2017
- Accepted November 30, 2017
- .
Author Information
- Veena S. Patil1,
- Ariel Madrigal1,
- Benjamin J. Schmiedel1,
- James Clarke1,2,
- Patrick O’Rourke1,
- Aruna D. de Silva1,3,*,
- Eva Harris4,
- Bjoern Peters1,5,
- Gregory Seumois1,
- Daniela Weiskopf1,
- Alessandro Sette1,5 and
- Pandurangan Vijayanand1,5,6,†
- 1Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037, USA.
- 2Cancer Sciences Unit, Faculty of Medicine, University of Southampton, Southampton, UK.
- 3Genetech Research Institute, Colombo, Sri Lanka.
- 4Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, Berkeley, CA 94720, USA.
- 5Department of Medicine, University of California San Diego, 9500 Gilman Drive #0656, La Jolla, CA 92093, USA.
- 6Clinical and Experimental Sciences, Sir Henry Wellcome Laboratories, Faculty of Medicine University of Southampton, Southampton, UK.
- ↵†Corresponding author. Email: vijay{at}lji.org